David Hsu - 09 Dec 2021 Form 4 Insider Report for MedMen Enterprises, Inc.

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
13 Dec 2021, 14:06:07 UTC
Prior SEC filing
22 Nov 2021
Next SEC filing
20 Sep 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ David Hsu

Key filing fact

David Hsu filed Form 4 for MedMen Enterprises, Inc. on 13 Dec 2021.

Key facts

  • This page summarizes David Hsu's Form 4 filing for MedMen Enterprises, Inc..
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 13 Dec 2021, 14:06.

Change

  • Previous filing in this sequence was filed on 22 Nov 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MMNFF transaction

Class B Subordinate Voting Shares

Award

Transaction value
$0
Shares
+14,924
Change %
Price
$0.000000
Shares after
14,924
Date
09 Dec 2021
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Class B Subordinate Voting Shares granted as part of Reporting Person's annual compensation for service as a director of Issuer.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .